Clinical Trial Capability Building work shop
The event conducted in KAIMRC on 17 & 18 of May 2022 The [...]
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial GallerySafety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial
Good Clinical Practice (GCP) Training
The Event Poster
KAIMRC collaborates with IQVIA to support COVID-19 clinical research in Saudi Arabia
On 22 September 2020, the King Abdullah International Medical Research Center (KAIMRC), [...]
Korea National Enterprise for Clinical Trials Training
Clinical trials are a cornerstone of medical R&D, a wellspring of jobs, [...]